Conference Coverage
Conference Coverage
In IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remission
SAN DIEGO – Minimal residual disease and mutational clearance were seen in a significant proportion of patients.
Video
FLT3 inhibitor moves forward in newly diagnosed AML
SAN DIEGO – Dr. Keith W. Pratz reviewed results from a phase 1 study of gilteritinib and next steps in newly diagnosed patients.
Conference Coverage
DOAC pause yields favorable outcomes for AF patients
SAN DIEGO – Results from the PAUSE study could set the standard for timing of perioperative DOAC interruption.
News
Early intervention initiative cut oncology patient hospitalizations
An after-hours phone triage system, proactive chemotherapy follow-up calls, and a Saturday-Sunday urgent care clinic resulted in early...
Video
Sickle cell disease guidelines release set for early 2019
SAN DIEGO – Five new ASH guidelines for sickle cell disease are on the way, likely early in 2019.
Conference Coverage
Emapalumab safe, effective in pediatric primary hemophagocytic lymphohistiocytosis
SAN DIEGO – There is “certainly room for enlarging the indication” to first-line treatment of HLH once a sufficient number of previously untreated...
Conference Coverage
Lower-dose rituximab may be enough in acquired TTP
SAN DIEGO – A lower dose of rituximab appears effective, but it still carries side effects.
Video
Model bests IPSS-R for predicting survival, risk for AML in myelodysplastic syndrome
Conference Coverage
TOURMALINE-MM3: Ixazomib improves PFS after myeloma transplant
SAN DIEGO – A leading investigator put the results in perspective with the currently approved lenalidomide, and the audience questions as to...
Video
JULIET: CAR T cells go the distance in r/r DLBCL
SAN DIEGO – Median overall survival among patients with complete responses to CAR-T cell therapy in the JULIET trial has not been reached.
Video
Beat AML trial delivers genomic results in 7 days
SAN DIEGO – The umbrella trial, sponsored by the Leukemia & Lymphoma Society, harnesses technology to speed genomic results that could...